TONGHUA DONGBAO PHARMACEUTICAL (600867.SH): short term profit is assisted by investment, but long term profit relies on insulin products

Search by Type

Report Charts News

Search by Company

Code Company name

TONGHUA DONGBAO PHARMACEUTICAL (600867.SH): short term profit is assisted by investment, but long term profit relies on insulin products

Date:2011-11-25xujintao

Operating revenue of Tonghua Dongbao Pharmaceutical reached RMB560 million in Jan. to Sept. 2011, up 21.2% YoY; while its operating profit achieved RMB480 million, a rise of 223.0% YoY. The main re...

Welcome to our website. This service is open to member only.

Registration

Contact our customer service team
Tel: 86-10-82600828, 82600893
Fax: 86-10-82601570
Email: report@researchinchina.com

Related Reports

China Heparin Industry Report, 2010-20112011-09-28
China Blood Products Industry Report, 2010-20112011-09-05
China Monoclonal Antibody Industry Report, 2010-20112011-07-05
China Insulin Industry Report, 20102011-01-25
China Heparin Industry Report, 20102010-12-18
China Blood Products Industry Report, 20102010-11-10
Global and China Biopharmaceutical Industry Report, 20102010-09-16
China Blood Products Industry Report, 20092009-10-13